Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double‐blind, 8‐week study

A majority of patients with hypertension fail to achieve blood pressure (BP) control despite treatment with commonly prescribed drugs. This randomized, double‐blind phase III trial assessed the superiority of sacubitril/valsartan 200 mg (97/103 mg) to continued olmesartan 20 mg in reducing ambulator...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Hypertens (Greenwich)
Egile Nagusiak: Cheung, Deanna G., Aizenberg, Diego, Gorbunov, Vladimir, Hafeez, Kudsia, Chen, Chien‐Wei, Zhang, Jack
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Drug Therapy
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8031201/
https://ncbi.nlm.nih.gov/pubmed/29338113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13153
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak